Germany's CureVac to launch human trial of experimental coronavirus vaccine - regulator
Published
Unlisted German biotech firm CureVac will become the second company to launch human trials of an experimental coronavirus vaccine in the country, Germany's vaccines regulator said on Wednesday.
Full Article